These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 14706257

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Spray dried powders and powder blends of recombinant human deoxyribonuclease (rhDNase) for aerosol delivery.
    Chan HK, Clark A, Gonda I, Mumenthaler M, Hsu C.
    Pharm Res; 1997 Apr; 14(4):431-7. PubMed ID: 9144727
    [Abstract] [Full Text] [Related]

  • 7. Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery.
    Zimmermann CM, Baldassi D, Chan K, Adams NBP, Neumann A, Porras-Gonzalez DL, Wei X, Kneidinger N, Stoleriu MG, Burgstaller G, Witzigmann D, Luciani P, Merkel OM.
    J Control Release; 2022 Nov; 351():137-150. PubMed ID: 36126785
    [Abstract] [Full Text] [Related]

  • 8. Characterization of spray dried powders with nucleic acid-containing PEI nanoparticles.
    Keil TWM, Feldmann DP, Costabile G, Zhong Q, da Rocha S, Merkel OM.
    Eur J Pharm Biopharm; 2019 Oct; 143():61-69. PubMed ID: 31445157
    [Abstract] [Full Text] [Related]

  • 9. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
    Li X, Vogt FG, Hayes D, Mansour HM.
    J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
    [Abstract] [Full Text] [Related]

  • 10. Spray drying lactose from organic solvent suspensions for aerosol delivery to the lungs.
    Ke WR, Chang RYK, Kwok PCL, Chen D, Chan HK.
    Int J Pharm; 2020 Dec 15; 591():119984. PubMed ID: 33069893
    [Abstract] [Full Text] [Related]

  • 11. Advanced design and development of nanoparticle/microparticle dual-drug combination lactose carrier-free dry powder inhalation aerosols.
    Muralidharan P, Mallory EK, Malapit M, Phan H, Ledford JG, Hayes D, Mansour HM.
    RSC Adv; 2020 Nov 17; 10(68):41846-41856. PubMed ID: 33391731
    [Abstract] [Full Text] [Related]

  • 12. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C, MacRitchie HB, Zeng XM, Martin GP.
    Int J Pharm; 2006 Dec 01; 326(1-2):39-49. PubMed ID: 16942848
    [Abstract] [Full Text] [Related]

  • 13. Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery.
    Pilcer G, Vanderbist F, Amighi K.
    Int J Pharm; 2009 Jan 05; 365(1-2):162-9. PubMed ID: 18782609
    [Abstract] [Full Text] [Related]

  • 14. Dry powder inhaler formulation of high-payload antibiotic nanoparticle complex intended for bronchiectasis therapy: Spray drying versus spray freeze drying preparation.
    Yu H, Teo J, Chew JW, Hadinoto K.
    Int J Pharm; 2016 Feb 29; 499(1-2):38-46. PubMed ID: 26757148
    [Abstract] [Full Text] [Related]

  • 15. Impact of dispersion media and carrier type on spray-dried proliposome powder formulations loaded with beclomethasone dipropionate for their pulmonary drug delivery via a next generation impactor.
    Khan I, Al-Hasani A, Khan MH, Khan AN, -Alam FE, Sadozai SK, Elhissi A, Khan J, Yousaf S.
    PLoS One; 2023 Feb 29; 18(3):e0281860. PubMed ID: 36913325
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Aerosol dispersion of respirable particles in narrow size distributions using drug-alone and lactose-blend formulations.
    Louey MD, Van Oort M, Hickey AJ.
    Pharm Res; 2004 Jul 29; 21(7):1207-13. PubMed ID: 15290861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.